0.00
price down icon100.00%   -2.27
 
loading
Acelyrin Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
See More
Previous Close:
$2.27
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$227.15M
Revenue:
-
Net Income/Loss:
$-299.80M
P/E Ratio:
0.00
EPS:
-2.84
Net Cash Flow:
$-217.49M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
Value
$0.00
$0.00
1-Week Range:
Value
$0.00
$0.00
52-Week Range:
Value
$0.00
$6.52

Acelyrin Inc Stock (SLRN) Company Profile

Name
Name
Acelyrin Inc
Name
Phone
805-456-4393
Name
Address
4149 LIBERTY CANYON RD., AGOURA HILLS
Name
Employee
83
Name
Twitter
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
SLRN's Discussions on Twitter

Compare SLRN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SLRN
Acelyrin Inc
0.00 227.15M 0 -299.80M -217.49M -2.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
374.98 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.90 60.58B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
418.91 54.99B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
674.90 42.25B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.23 32.93B 3.81B -644.79M -669.77M -6.24

Acelyrin Inc Stock (SLRN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-14-24 Downgrade H.C. Wainwright Buy → Neutral
Jul-08-24 Upgrade Wells Fargo Equal Weight → Overweight
Dec-13-23 Initiated Wells Fargo Equal Weight
Dec-08-23 Initiated Citigroup Neutral
Sep-13-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-05-23 Initiated H.C. Wainwright Buy
May-30-23 Initiated Jefferies Buy
May-30-23 Initiated Morgan Stanley Overweight
May-30-23 Initiated Piper Sandler Overweight
May-30-23 Initiated TD Cowen Outperform
View All

Acelyrin Inc Stock (SLRN) Latest News

pulisher
Aug 04, 2025

What are analysts’ price targets for Acelyrin Inc. in the next 12 monthsInvest like a pro with expert recommendations - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

How does Acelyrin Inc. compare to its industry peersInvest confidently with professional guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Acelyrin Inc. stockTurn market volatility into profit opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What markets is Acelyrin Inc. expanding into Is SEVN stock a good long term investment option - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Acelyrin Inc. stockSky-high return potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Acelyrin Inc. stockFree Expert Stock Watchlist - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Acelyrin Inc. stock higher in 2025Master stock selection with insider knowledge - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Acelyrin Inc. stock overvalued or undervaluedBuild wealth faster with disciplined trading - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Acelyrin Inc. stock in 2025Exceptional stock performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Acelyrin Inc. stock compared to the marketCapitalize on emerging market opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Why is Acelyrin Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk management - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

How does Acelyrin Inc. generate profit in a changing economyPre Market Trend Scanner From AI Tools - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about Acelyrin Inc.Post Market Outlook For Every Investor - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

What is the risk reward ratio of investing in Acelyrin Inc. stockWealth Building Growth Plan For Consistent Profits - Jammu Links News

Jul 30, 2025
pulisher
Jul 29, 2025

Alumis (ALMS) Merges with ACELYRIN - Insider Monkey

Jul 29, 2025
pulisher
Jul 29, 2025

Sentiment Tools Show Shift in Trader Mood on Acelyrin Inc.AI Screening for Swing Trade Picks Finds Momentum - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Fibonacci Support Holding Strong in Acelyrin Inc.Secure Capital Picks With Upside Potential Tracked - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What makes Acelyrin Inc. stock price move sharplyReliable Alerts for Daily Stock Movers Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 22:52:55 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Acelyrin Inc. as a “Buy”Entry Signal Trend Scanner For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Acelyrin Inc. Company’s Quarterly Earnings Growth: What the Numbers SayReliable High Profit Alerts - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Is Acelyrin Inc. Stock a Smart Buy in 2025 Investment Analysis InsideBig Profit Small Risk Alerts - beatles.ru

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Acelyrin Inc. stock priceFree Predictions - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Acelyrin Inc. a good long term investmentExceptional profit velocity - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Does Acelyrin Inc. stock pay reliable dividendsConsistent wealth multiplication - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 23, 2025

Acelyrin Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Acelyrin Inc. stockTriple-digit wealth increases - Autocar Professional

Jul 23, 2025

Acelyrin Inc Stock (SLRN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.72
price down icon 0.40%
$37.91
price up icon 0.08%
$111.61
price up icon 0.33%
$29.13
price down icon 0.65%
$111.07
price up icon 0.95%
biotechnology ONC
$307.23
price up icon 0.96%
Cap:     |  Volume (24h):